In some embodiments, the lipid-based drug delivery formulation or composition is a phospholipid-based formulation or composition wherein the natural or synthetic phospholipid is phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, phosphatidic acid, lysophospholipids, egg or soybean phospholipid, or a combination thereof
Note: An Expression of Concern has been issued for this paper (PMID 34551989, 2021)
GLP- 1 Receptor Agonists in Combination with Insulin The GLP- 1 receptor agonists have been shown to improve blood glucose control when used in conjunction with insulin, particularly basal insulin, and may be particularly useful in the treatment of advanced T2DM [108]
Their mean age and body mass index were 36.5 years and 28 kg/m 2 , respectively
BPC-157, also known by the names bepecin, PL 14736, PL-10, and PLD-116, is a synthetic peptide chain classified as a pentadecapeptide due to its structure of 15 amino acids